Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
18.48
-0.09 (-0.48%)
At close: Oct 30, 2026, 4:00 PM EDT
19.89
+1.41 (7.63%)
After-hours: Oct 30, 2026, 7:56 PM EDT

Nuvectis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
60258020519315322322910511711614614522225619311010414294--
Market Cap Growth (YoY)
249.37%159.82%-10.39%85.02%30.62%92.04%56.85%-27.66%-47.15%-54.55%-24.66%31.58%113.82%79.47%105.23%------
Enterprise Value
5805551731581261932108799971271221972401738690126104--
Last Close Price
18.4818.397.737.556.027.479.775.416.296.338.208.3412.8915.9713.117.507.0911.207.41--

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
PB Ratio
54.3263.8414.4010.506.3813.2310.9110.7610.689.2810.3911.8413.3012.5715.767.725.1012.396.47--
P/TBV Ratio
66.3063.8414.4010.506.3813.2310.9110.7610.689.2810.3911.8413.3012.5715.767.725.1012.396.47--

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
Net Debt / Equity Ratio
-2.44-2.44-1.77-1.72-1.48-1.59-1.42-1.91-1.56-1.45-1.39-1.57-1.32-1.21-1.26-1.41-1.16-1.18-1.15-1.35-
Quick Ratio
1.671.672.252.383.062.643.252.082.723.143.422.743.965.343.933.235.264.965.462.37-
Current Ratio
1.681.682.272.383.072.673.282.092.743.173.462.753.995.414.123.305.545.205.762.41-
Return on Equity (ROE)
-214.58%-214.58%-154.43%-188.03%-145.00%-150.12%-115.28%-173.41%-140.00%-128.44%-170.23%-168.51%-120.53%-140.30%-150.49%-206.81%----609.74%-
Return on Assets (ROA)
-73.07%-73.07%-63.61%-68.50%-62.40%-63.38%-52.69%-65.64%-60.86%-60.89%-77.22%-69.14%-57.32%-68.24%-70.91%-83.30%-----
Return on Capital Employed (ROCE)
-317.90%-317.90%-198.80%-149.80%-110.00%-136.10%-100.30%-204.30%-175.30%-168.10%-158.30%-179.50%-129.50%-105.20%-156.30%-126.80%-37.40%-55.20%-59.90%-136.70%240.00%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q4 2020
Period Ending
Oct '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Dec '20
Earnings Yield
-7.06%-4.80%-13.26%-13.67%-16.56%-9.89%-8.82%-18.18%-16.51%-18.16%-15.36%-15.40%-10.06%-8.73%-10.44%-17.38%-14.11%-9.44%-16.78%--
Buyback Yield / Dilution
-21.66%-21.66%-26.31%-27.46%-22.30%-16.00%-12.13%-10.01%-10.23%-12.32%-14.00%-22.90%-49.95%-89.00%-151.63%-196.55%-159.45%----
SEC Filings: 10-K · 10-Q